Oncoinvent has reached the halfway enrollment point in its Phase 2 trial of Radspherin, an experimental alpha-radiation therapy for ovarian cancer patients with peritoneal metastases, as recruitment accelerates across multiple international clinical sites.
Phase II Clinical Trial | 20/06/2026 | By News Bureau | 142
Omnix Medical has initiated patient dosing in its Phase 2 clinical trial of OMN6, a novel antimicrobial peptide designed to treat severe multidrug-resistant Acinetobacter baumannii infections, a critical global health threat with limited treatment options.
Phase II Clinical Trial | 05/06/2026 | By News Bureau
Vensica Medical Secures US FDA Clearance to Advance Needle-Free OAB Therapy to Phase II
Vensica Medical moves forward with clinical trials of its needle-free drug delivery platform aimed at improving access and patient comfort in overactive bladder treatment.
Phase II Clinical Trial | 01/05/2026 | By News Bureau | 109
AskBio Completes Enrollment for Phase 2 Gene Therapy Trial Targeting Heart Failure
The GenePHIT study evaluating investigational therapy AB-1002 for heart failure with reduced ejection fraction has fully enrolled 173 patients, with initial results expected in early 2027.
Phase II Clinical Trial | 02/04/2026 | By News Bureau | 110
Arch Biopartners Advances Phase II Trial of LSALT Peptide as New Site Begins Patient Dosing
Arch Biopartners advances LSALT peptide trial for acute kidney injury as new clinical site initiates patient dosing and global expansion plans progress.
Phase II Clinical Trial | 24/03/2026 | By News Bureau
Clover Biopharmaceuticals Completes Initial Enrollment in Phase II Trial of RSV Combination Vaccines
The Australia-based Phase II study is evaluating Clover’s protein-based combination vaccine candidates SCB-1022 and SCB-1033 targeting RSV, hMPV and PIV3 in older adults, using its proprietary Trimer-Tag technology.
Phase II Clinical Trial | 12/01/2026 | By News Bureau | 575
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy